Drawing for S-PEDITE

USPTO serial 79337934

S-PEDITE

Reviewed by CopyMark Law Group

Reg. 6966222Status 700Registered
Filing date
Status date
Registration date
Jan 31, 2023
Examiner
EINSTEIN, MATTHEW T
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with S-PEDITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian P. Gregg

Brian P. Gregg McNees Wallace & Nurick100 Pine StreetHarrisburg, PA 17108UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
040Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; generation of cell line for the manufacture of biopharmaceutical materials, namely, biomanufacturing for others in the nature of biopharmaceuticals using biological organisms in the manufacturing process; chemical treatment of liquids; custom manufacturing services in the nature of processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicalsACTIVE—
042Medical research in the field of crude drugs; development of cell therapy products; development of pharmaceutical preparations and medicines; drug development; inspection of pharmaceuticals; research of pharmaceuticals; scientific research in the nature of conducting clinical testing of medicine for others; pharmaceutical products evaluation; research of medical product; bacteriological research and analysis; medical laboratory services; stem cell research services; conducting clinical trials for others; medicine research; research and development of technology for biotechnology; microbial culture trials, namely, conducting clinical trials for others; biochemistry research services; genetic research for scientific purposes; scientific research in the field of genetic engineeringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 8, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 8, 2023FIMPFINAL DISPOSITION PROCESSED—
Apr 30, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 31, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 31, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 15, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 15, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 26, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 11, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 5, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 5, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2022RFNTREFUSAL PROCESSED BY IB—
May 6, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 6, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 28, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2022DOCKASSIGNED TO EXAMINER—
Apr 19, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 15, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 14, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance